{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:06:12Z","timestamp":1773335172445,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Circulating factor R-spondin 2 (RSPO2) has been found to play a role in lipid metabolism and insulin resistance. However, its relationship with kidney injury and diabetic kidney disease (DKD) remains unclear. We aim to determine the expression levels of RSPO2 in patients with type 2 diabetes mellitus (T2DM) stratified by kidney disease risk, and analyze its correlations with the parameters of renal injury parameters, glucose and lipid profiles, and further investigate the association between plasma RSPO2 concentration and the prognosis risk of DKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 121 participants with T2DM were enrolled and categorized into four kidney disease risk groups (Low, Moderately Increased, High, and Very High Risk) based on estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR). Relevant anthropometric and biochemical parameters were analyzed, and plasma RSPO2 concentrations were measured. Spearman\u2019s correlation analysis and Multiple logistic regression analysis was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Plasma RSPO2 concentrations were significantly elevated in the High and Very High Risk groups compared to the Low and Moderately Increased Risk groups.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , RSPO2 expression levels were elevated in kidney tissues of DKD mouse models. Spearman correlation analysis revealed that the plasma RSPO2 level was positively correlated with UACR, Urea, serum creatinine and history of hypertension, while negatively correlated with eGFR, diastolic blood pressure (DBP), drinking and metformin usage after adjusting for age. Multivariate logistic regression analysis demonstrated that a higher plasma RSPO2 concentration remained significantly associated with progression to a more severe kidney disease risk grade after adjusting for potential confounders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated plasma RSPO2 concentration is independently associated with higher kidney disease risk in patients with T2DM and may serve as a potential biomarker for DKD progression. Further studies are needed to elucidate the role of RSPO2 in DKD and its underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1787296","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:28:30Z","timestamp":1773293310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma R-spondin 2 levels are associated with the progression of diabetic kidney disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuren","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaran","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongting","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, The Second Affiliated Hospital of Army Medical University","place":["Chongqing, China"]},{"name":"The Second Affiliated Hospital of Guizhou University of TCM","place":["Guiyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","article-title":"Mechanisms of diabetic kidney disease and established and emerging treatments","volume":"22","author":"Martinez Leon","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"eadn1507","DOI":"10.1126\/scitranslmed.adn1507","article-title":"Inhibition of CCL7 improves endothelial dysfunction and vasculopathy in mouse models of diabetes mellitus","volume":"16","author":"Chang","year":"2024","journal-title":"Sci Transl Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-021-00542-2","article-title":"FGF1(DeltaHBS) prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK\/Nur77 suppression","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0118-y","article-title":"RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4\/5\/6","volume":"557","author":"Szenker-Ravi","year":"2018","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08677-w","article-title":"Hepatic stellate cells control liver zonation, size and functions via R-spondin 3","volume":"640","author":"Sugimoto","year":"2025","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cell.2018.07.027","article-title":"Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis","volume":"174","author":"Nanki","year":"2018","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng1883","article-title":"The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia","volume":"38","author":"Blaydon","year":"2006","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1086\/509789","article-title":"Mutations in the gene encoding the Wnt-signaling component R-spondin 4 (RSPO4) cause autosomal recessive anonychia","volume":"79","author":"Bergmann","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701078","article-title":"Mutations in R-spondin 4 (RSPO4) underlie inherited anonychia","volume":"128","author":"Ishii","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701088","article-title":"RSPO4 is the major gene in autosomal-recessive anonychia and mutations cluster in the furin-like cysteine-rich domains of the Wnt signaling ligand R-spondin 4","volume":"128","author":"Bruchle","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2018.0066","article-title":"Serum R-spondin 1 is a new surrogate marker for obesity and insulin resistance","volume":"43","author":"Kang","year":"2019","journal-title":"Diabetes Metab J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s42255-021-00509-1","article-title":"Identification of a regulatory pathway inhibiting adipogenesis via RSPO2","volume":"4","author":"Dong","year":"2022","journal-title":"Nat Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8406","DOI":"10.1038\/s41467-025-63410-5","article-title":"Cryo-EM structure of the full-length LGR4-RSPOs complex and a targeting nanobody for anti-obesity therapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101551","article-title":"R-spondin 2 suppresses hepatic steatosis via activation of AMPK-ACC signaling","volume":"7","author":"Aithabathula","year":"2025","journal-title":"JHEP Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa244","article-title":"Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis","volume":"117","author":"Singla","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112713","article-title":"Silencing of RSPO1 mitigates obesity-related renal fibrosis in mice by deactivating Wnt\/beta-catenin pathway","volume":"405","author":"Su","year":"2021","journal-title":"Exp Cell Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112474","article-title":"Integrative analysis identifies novel proteins associated with chronic kidney disease in participants with abnormal glucose metabolism","volume":"229","author":"Li","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1113","article-title":"Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes","volume":"23","author":"Gabir","year":"2000","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2400819","DOI":"10.1002\/advs.202400819","article-title":"CD9 counteracts liver steatosis and mediates GCGR agonist hepatic effects","volume":"11","author":"Zheng","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"334ra51","DOI":"10.1126\/scitranslmed.aad6095","article-title":"NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis","volume":"8","author":"Wang","year":"2016","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","article-title":"Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism","volume":"32","author":"Fu","year":"2020","journal-title":"Cell Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2306365","DOI":"10.1002\/advs.202306365","article-title":"Dock5 deficiency promotes proteinuric kidney diseases via modulating podocyte lipid metabolism","volume":"11","author":"Qu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"De Boer","year":"2011","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0140-6736(22)01546-X","article-title":"The path to healthy ageing in China: a Peking University-Lancet Commission","volume":"400","author":"Chen","year":"2022","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.197","article-title":"The role of the glomerular endothelium in albumin handling","volume":"9","author":"Satchell","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018111166","article-title":"Changes in albuminuria but not GFR are associated with early changes in kidney structure in type 2 diabetes","volume":"30","author":"Looker","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e2348333","DOI":"10.1001\/jamanetworkopen.2023.48333","article-title":"Urinary albumin-to-creatinine ratio in normal range, cardiovascular health, and all-cause mortality","volume":"6","author":"Mahemuti","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S011","article-title":"11. Microvascular complications and foot care: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2207152","DOI":"10.1002\/advs.202207152","article-title":"Human RSPO1 mutation represses beige adipocyte thermogenesis and contributes to diet-induced adiposity","volume":"10","author":"Sun","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.89281","article-title":"Deciphering the complex relationship between type 2 diabetes and fracture risk with both genetic and observational evidence","volume":"12","author":"Zhao","year":"2024","journal-title":"Elife"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111790","article-title":"Proteomics profiling and association with cardiorenal complications in type 2 diabetes subtypes in Asian population","volume":"214","author":"Gurung","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155979","article-title":"Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis","volume":"159","author":"Zhao","year":"2024","journal-title":"Metabolism"},{"key":"B35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13287-021-02385-8","article-title":"Rspo3 regulates the abnormal differentiation of small intestinal epithelial cells in diabetic state","volume":"12","author":"Shan","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/nu17122049","article-title":"High dietary phosphorus impairs bone microarchitecture and induces alterations in the LGR4-R-spondins axis in rats with normal renal function","volume":"17","author":"Fernandez-Villabrille","year":"2025","journal-title":"Nutrients"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144579","article-title":"RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis","volume":"132","author":"Yue","year":"2022","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317632","article-title":"RSPO2 gene rearrangement: a powerful driver of beta-catenin activation in liver tumours","volume":"68","author":"Longerich","year":"2019","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1038\/ncomms4149","article-title":"RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer","volume":"5","author":"Wu","year":"2014","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1327","article-title":"RSPO2 enhances canonical wnt signaling to confer stemness-associated traits to susceptible pancreatic cancer cells","volume":"75","author":"Ilmer","year":"2015","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222773","article-title":"Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis","volume":"82","author":"Knights","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213450","article-title":"Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2","volume":"77","author":"Zhang","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1787296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:28:31Z","timestamp":1773293311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1787296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":42,"alternative-id":["10.3389\/fendo.2026.1787296"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1787296","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"article-number":"1787296"}}